Therapeutics Related News

Intellia Therapeutics Demonstrates Pioneering CRISPR/Cas9 Genome Editing Efficiency Data Using Lipid Nanoparticle Delivery Technology

CAMBRIDGE, Mass., March 08, 2017 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on the development of potentially curative therapies, today reported updated data showing increased levels of genome editing efficiency in vivo and durability [...]

By | March 9th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Kite Pharma’s Engineered T-Cell Therapies for Cancers Delivers Astonishing Results

Kite Pharma’s gene therapy trial has just delivered astonishing results: 41% of patients in response and 36% in complete response at month 6 after a single round of treatment. The news shook the bio and med industry last week, skyrocketing [...]

By | March 7th, 2017|BioPharma & Healthcare, News, Therapeutics|

Inovio Reports New Positive Clinical Data on Vaccine Advances in the Fight Against Emerging Infectious Diseases

PLYMOUTH MEETING, Pa., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that Dr. David B. Weiner, Inovio’s co-founder, presented positive clinical data on Inovio’s DNA-based vaccines against MERS (Middle East Respiratory Syndrome) (GLS-5300) and Zika (GLS-5700) [...]

By | February 26th, 2017|BioPharma & Healthcare, News, Pharmaceuticals, Press Releases, Therapeutics|

Isogenica Announces New Licence Agreement With Top-25 Global Pharmaceutical Company

Cambridge, UK | 21st February 2017. Isogenica Ltd, a leader in the design and construction of innovative and highly diverse synthetic antibody libraries, today announced a new licensing deal with a top-25 global pharmaceutical company which specialises in immunology, oncology and [...]

By | February 21st, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Cell Design Labs’ Scientific Founder Co-Authors Review Article Illustrating Power and Potential of Engineered Human Cells to Treat Cancer

EMERYVILLE, Calif., Feb. 09, 2017 (GLOBE NEWSWIRE) -- Cell Design Labs, Inc. today announced that its scientific founder, Wendell Lim, Ph.D., co-authored a comprehensive review article on engineered cell therapies entitled, “The Principles of Engineering Immune Cells to Treat Cancer” [...]

By | February 14th, 2017|BioPharma & Healthcare, News, Press Releases, Therapeutics|

Meet the Speakers: Will Synthetic Biology be the Key to Our Future Health?

SynBioBeta’s fifth annual London conference is fast approaching, with leaders in industry, academia, and investment once again set to converge on Imperial College London between April 4th and 6th. A full schedule of exciting events and sessions has been lined [...]

By | February 1st, 2017|BioPharma & Healthcare, News, Pharmaceuticals, Therapeutics|